Ryan Asay | analyst |
Mark Goldsmith | executive |
Jack Anders | executive |
Marc Frahm | analyst |
Michael Schmidt | analyst |
Wei Lin | executive |
Eric Joseph | analyst |
Jonathan Chang | analyst |
Chris Shibutani | analyst |
Elliott Bosco | analyst |
Alec Stranahan | analyst |
Stephen Kelsey | executive |
Dingding Shi | analyst |
Jay Olson | analyst |
Laura Prendergast | analyst |
Joseph Catanzaro | analyst |
Good day, and thank you for standing by. Welcome to the Revolution Medicines Q2 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Ryan Asay, Senior Vice President of Corporate Affairs. Please go ahead.